Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: Results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial

American Heart Journal

Volumn 170, Issue 4, 2015, Pages 787-795.e1

  Kurz, David J ^a   Bernheim, Alain M ^a   Tüller, David ^a   Zbinden, Rainer ^a   Jeger, Raban ^b   Kaiser, Christoph ^b   Galatius, Soeren ^c   Hansen, Kim W ^c   Alber, Hannes ^d   Pfisterer, Matthias ^b   Eberli, Franz R ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL CORONARY STENT; BARE METAL STENT; CARDIAC PATIENT; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DEVICE COMPARISON; DEVICE SAFETY; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; SIROLIMUS ELUTING CORONARY STENT; STENT THROMBOSIS; VALIDATION STUDY; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CORONARY BLOOD VESSEL; DRUG ELUTING STENT; EPIDEMIOLOGY; EUROPE; MIDDLE AGED; MORTALITY; PROCEDURES; PROSTHESIS; RADIOGRAPHY; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; EUROPE; EVEROLIMUS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84941939357     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.07.009     Document Type: Article

References (22)

1. E.G. Lakatta, and D. Levy Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease Circulation 107 2003 139 146
2. T.Y. Wang, A. Gutierrez, and E.D. Peterson Percutaneous coronary intervention in the elderly Nat Rev Cardiol 8 2011 79 90
3. K.P. Alexander, M.T. Roe, A.Y. Chen, and et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative J Am Coll Cardiol 46 2005 1479 1487
4. M. Singh, E.D. Peterson, M.T. Roe, and et al. Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience Circ Cardiovasc Interv 2 2009 20 26
5. M.P. Thomas, M. Moscucci, D.E. Smith, and et al. Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Clin Cardiol 34 2011 549 554
6. C. Johnman, K.G. Oldroyd, D.F. Mackay, and et al. Percutaneous coronary intervention in the elderly: changes in case-mix and periprocedural outcomes in 31,758 patients treated between 2000 and 2007 Circ Cardiovasc Interv 3 2010 341 345
7. G.G. Stefanini, and D.R. Holmes Drug-eluting coronary-artery stents N Engl J Med 368 2013 254 265
8. T.Y. Wang, F.A. Masoudi, J.C. Messenger, and et al. Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States J Am Coll Cardiol 59 2012 105 112
9. P.W. Groeneveld, M.A. Matta, A.P. Greenhut, and et al. Drug-eluting compared with bare-metal coronary stents among elderly patients J Am Coll Cardiol 51 2008 2017 2024
10. E. Puymirat, F. Mangiacapra, A. Peace, and et al. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease Arch Cardiovasc Dis 106 2013 554 561
11. A. de Belder, J.M. de la Torre Hernandez, R. Lopez-Palop, and et al. A prospective randomized trial of everolimus-eluting stents versus bare metal stents in octogenarians: Xience Or Vision Stents For The Management Of Angina In The Elderly - the Xima trial J Am Coll Cardiol 63 2014 1371 1375
12. National Institute for Clinical Excellence (NICE) Drug-eluting stents for the treatment of coronary artery disease Technology Appraisal 152 2008 [ http://publications.nice.org.uk/drug-eluting-stents-for-the-treatment-of-coronary-artery-disease-ta152 ]
13. H.P. Brunner-La Rocca, C. Kaiser, and M. Pfisterer Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET) Eur Heart J 28 2007 719 725
14. J.V. Tu, J. Bowen, M. Chiu, and et al. Effectiveness and safety of drug-eluting stents in Ontario N Engl J Med 357 2007 1393 1402
15. C. Kaiser, S. Galatius, P. Erne, and et al. Drug-eluting versus bare-metal stents in large coronary arteries N Engl J Med 363 2010 2310 2319
16. M. Pfisterer, O. Bertel, P.O. Bonetti, and et al. Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design Am Heart J 155 2008 609 614
17. D.E. Cutlip, S. Windecker, R. Mehran, and et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
18. S.V. Rao, K. O'Grady, K.S. Pieper, and et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes J Am Coll Cardiol 47 2006 809 816
19. A. Ielasi, S. Brugaletta, A. Silvestro, and et al. Everolimus-eluting stent versus bare-metal stent in elderly (≥75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial Int J Cardiol 179 2015 73 78
20. S.H. Pedersen, M. Pfisterer, C. Kaiser, and et al. Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial EuroIntervention 10 2014 58 64
21. L. Raber, H. Kelbaek, M. Ostojic, and et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial JAMA 308 2012 777 787
22. M. Sabate, A. Cequier, A. Iniguez, and et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490